A chilling investigation has uncovered a disturbing truth: the globalist elites are using AI algorithms to deny medical care to elderly patients on Medicare Advantage, furthering their depopulation agenda.
Shockingly, these unregulated predictive tools are being used by health insurance companies to cut off benefits for vulnerable patients, ignoring the opinion of human doctors and delaying treatment for seriously ill individuals. As more Americans over 65 and those with disabilities choose these lower premium plans, Medicare Advantage has become increasingly profitable for insurers, and they’re using these AI death panels to deny care and potentially hasten the demise of the nation’s sickest patients.
The report found that AI algorithms used by Medicare Advantage insurers are increasingly driving denials of care, potentially affecting millions of older Americans who rely on the taxpayer-funded program. In some cases, insurers are cutting off benefits for elderly patients because the AI says they should be better, ignoring human doctors’ opinions. The algorithms’ recommendations conflict with basic rules on what Medicare plans must cover, creating disputes between doctors and insurers, and often delaying treatment for seriously ill patients.
The investigation highlighted the case of Frances Walter, an 85-year-old Wisconsin woman who had a broken left shoulder and an allergy to painkillers. Despite requiring further assistance, her Medicare Advantage insurer, Security Health Plan, cut off payment for her care after 17 days, following the algorithm’s estimate, which didn’t consider the opinion of her human doctor. Walter had to spend her life savings and enroll in Medicaid to continue her treatment.
Health insurance companies are increasingly using unregulated predictive algorithms to determine when to stop payments for older patients’ treatments. Although the insurers claim that these tools are merely suggestive, in practice, they often serve as hard-and-fast rules that don’t account for individual circumstances or changes in a patient’s conditions. As more Americans over 65 and those with disabilities choose plans with lower premiums and prescription drug coverage, Medicare Advantage has become more profitable for insurers.
The FDA assesses the AI models used by doctors to identify diseases like cancer or recommend the best treatment. In contrast, the tools used by insurers to decide whether to pay for those treatments are not subjected to the same scrutiny, despite their impact on the care of the nation’s sickest patients. The lack of regulation and oversight of these predictive algorithms raises concerns about the impact on patient care and treatment access. As the influence of these tools continues to grow, the precise role they play in insurers’ decisions remains opaque.
This report raises important questions about the ethical use of AI in healthcare and the potential consequences for vulnerable patients who depend on Medicare for their medical needs. The increasing reliance on AI algorithms to make crucial decisions about patient care is raising concerns among medical professionals and patient advocates. It’s time to take a closer look at the impact of this technology on the healthcare sector and whether it’s being used to fulfill a depopulation agenda.